Aditi Shastri, MD (@aditishasmd) 's Twitter Profile
Aditi Shastri, MD

@aditishasmd

Assoc Prof, Physician-scientist researching cures for AML & MDS. Addressing health disparities in cancer care. #shastrilab Tweets my own #leusm #mds

ID: 872903587155857408

linkhttp://www.einstein.yu.edu/faculty/14819/aditi-shastri/ calendar_today08-06-2017 19:50:07

3,3K Tweet

1,1K Takipçi

438 Takip Edilen

Mark Dawson (@maf_dawson) 's Twitter Profile Photo

Thrilled to share a wonderful collaboration with Scott Armstrong Florian Perner Shellaina Gordon !! Catalytic inhibition of KAT6/KAT7 enhances the efficacy and overcomes primary and acquired resistance to Menin inhibitors in MLL leukaemia biorxiv.org/content/10.110…

Zhuoer (Zoey) Xie, MD, MSCR (@zhuoerxie) 's Twitter Profile Photo

🚨 Excited to share our new Blood Neoplasia manuscript! 😊 ✨🔑 CG clone size predicts cell counts, blasts, TP53MT, Rx response & independently boosts OS/LFS predictions, refining IPSS-R/M!! Moffitt Cancer Center Moffitt Research #MDS 📖 doi.org/10.1016/j.bneo…

Sanam Loghavi, MD صنم لغوی 🔬🧬 (@sanamloghavi) 's Twitter Profile Photo

New 📄🚨on everyone's least favorite myeloid neoplasms:TP53m AML&MDS 🧵In short: 🔴pls don’t exclude these pts of allo-HSCT, their only chance at cure.   🔴TP53 burden is key 🔴Blasts matter (for real… not only b/c I’m a pathologist 🔬😉) haematologica.org/article/view/1…

New 📄🚨on everyone's least favorite myeloid neoplasms:TP53m AML&MDS 🧵In short:
🔴pls don’t exclude these pts of allo-HSCT, their only chance at cure.  
🔴TP53 burden is key
🔴Blasts matter (for real… not only b/c I’m a pathologist 🔬😉)
haematologica.org/article/view/1…
Dr. Uma Borate: Associate Professor (@beatalleukemia) 's Twitter Profile Photo

Watch for short & sweet #ASH24 Acute Leukemia takeaways for my wonderful community oncology colleagues. 🙏🏽 Oncology Brothers for the opportunity and the great work you do !

Charan Thej Reddy Vegivinti (@charanvegivinti) 's Twitter Profile Photo

Excited to share our paper on the preclinical efficacy of two novel ALK5 inhibitors, IOA-359 and IOA-360, in stimulating erythroid differentiation in MDS and AML. Grateful to Amit Verma and @ Nandini for their support and opportunity! iOnctura.

Excited to share our paper on the preclinical efficacy of two novel ALK5 inhibitors, IOA-359 and IOA-360, in stimulating erythroid differentiation in MDS and AML. Grateful to <a href="/Amitvermamds/">Amit Verma</a> and @ Nandini for their support and opportunity! <a href="/iOnctura/">iOnctura</a>.
Amer Zeidan MBBS,MHS ‏عامر زيدان (@dr_amerzeidan) 's Twitter Profile Photo

Kicking off 2025 with this outstanding International Consortium for MDS (icMDS) first online @BloodJournal effort that every clinical researcher, regulator, industry sponsor, reviewer, or anyone involved involved in #MDSsm clinical trials should read before writing or approving an #MDSsm clinical trial protocol

Kicking off 2025 with this outstanding <a href="/ic_MDS/">International Consortium for MDS (icMDS)</a> first online @BloodJournal effort that every clinical researcher, regulator, industry sponsor, reviewer, or anyone involved involved in #MDSsm clinical trials should read before writing or approving an #MDSsm clinical trial protocol
Albert Einstein College of Medicine - Official (@einsteinmed) 's Twitter Profile Photo

Teresa Bowman, Ph.D., received Einstein's inaugural Dr. Fernando Macian-Juan Award for Excellence in Graduate Student Mentoring. The award honors the memory of Dr. Macian-Juan, a professor of pathology for more than 20 years. Learn more at bit.ly/4g4M6a5 #MentoringMonth

Teresa Bowman, Ph.D., received Einstein's inaugural Dr. Fernando Macian-Juan Award for Excellence in Graduate Student Mentoring. The award honors the memory of Dr. Macian-Juan, a professor of pathology for more than 20 years. Learn more at bit.ly/4g4M6a5 #MentoringMonth
Dr. Uma Borate: Associate Professor (@beatalleukemia) 's Twitter Profile Photo

Publication alert 👉👉👉 on behalf of the International Consortium for MDS (icMDS) in @BloodJournal , 'Reducing Clinical Trial Eligibility Barriers for MDS :An icMDS Position Statement'. This paper demonstrates how eligibility criteria for LR & HR MDS often do not vary across trial phases & don't reflect known

Publication alert 👉👉👉 on behalf of the <a href="/ic_MDS/">International Consortium for MDS (icMDS)</a> in @BloodJournal , 'Reducing Clinical Trial Eligibility Barriers for MDS :An icMDS Position Statement'. This paper demonstrates how eligibility criteria for LR &amp; HR MDS often do not vary across trial phases &amp; don't reflect known
Keisuke Ito_Lab (@the_ito_lab) 's Twitter Profile Photo

Enjoyed a wonderful dinner at City Island with Dr. Peng Ji Peng Ji (Northwestern), an EinsteinPhD alum, Dr. Richard Stanley, and Albert Einstein College of Medicine - Official colleagues! Thoroughly appreciated Peng’s incredible DMB Liang Zhu Memorial Lecture and the engaging conversations!

Enjoyed a wonderful dinner at City Island with Dr. Peng Ji <a href="/PengJi_lab/">Peng Ji</a> (<a href="/NorthwesternU/">Northwestern</a>), an <a href="/EinsteinPhD/">EinsteinPhD</a> alum, Dr. Richard Stanley, and <a href="/EinsteinMed/">Albert Einstein College of Medicine - Official</a> colleagues! Thoroughly appreciated Peng’s incredible DMB Liang Zhu Memorial Lecture and the engaging conversations!
Aditi Shastri, MD (@aditishasmd) 's Twitter Profile Photo

Practice-changing study from Ioannis Mantzaris Montefiore Health System in @BloodJournal adding Ven frontline to globally used AML doublet 3+7 ⬆️ response rates ⬆️application. Happy to be a part of it! #leusm EinsteinSCI

Simone Sidoli (@simonesidoli) 's Twitter Profile Photo

We are very excited to officially launch our single cell proteomics service!! Please, check out our website if you want to work with us! sidolilab.org/single-cell

We are very excited to officially launch our single cell proteomics service!! Please, check out our website if you want to work with us!
sidolilab.org/single-cell
Rahul Banerjee, MD, FACP (@rahulbanerjeemd) 's Twitter Profile Photo

😔 Outdoor air pollution (OAP) was an independent predictor of worsened outcomes in myeloma #MMsm. Elegant epidemiological data from the Bronx (NYC, 🇺🇸 ) by Wysota Aditi Shastri, MD et al, but also applicable to patients around the world…

😔

Outdoor air pollution (OAP) was an independent predictor of worsened outcomes in myeloma #MMsm. 

Elegant epidemiological data from the Bronx (NYC, 🇺🇸 ) by Wysota <a href="/aditishasMD/">Aditi Shastri, MD</a> et al, but also applicable to patients around the world…
Aditi Shastri, MD (@aditishasmd) 's Twitter Profile Photo

In our study just published in Blood Cancer Journal Outdoor Air Pollution(OAP) , particularly PM2.5 was associated with a trend towards worse survival in #multiplemyeloma patients treated in a historically redlined area - Bronx, NY. EinsteinSCI Montefiore Health System Albert Einstein College of Medicine - Official